Literature DB >> 17286616

Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection.

F Veronese1, S Rotman, R N Smith, T D Pelle, M L Farrell, T Kawai, A Benedict Cosimi, R B Colvin.   

Abstract

The localization and significance of regulatory T cells (Treg) in allograft rejection is of considerable clinical and immunological interest. We analyzed 80 human renal transplant biopsies (including seven donor biopsies) with a double immunohistochemical marker for the Treg transcription factor FOXP3, combined with a second marker for CD4 or CD8. Quantitative FOXP3 cell counts were performed and analyzed for clinical and pathologic correlates. FOXP3(+) cells were present in the interstitium in acute cellular rejection (ACR) type I and II, at a greater density than in acute humoral rejection or CNI toxicity (p < 0.01). Most FOXP3(+) cells were CD4(+) (96%); a minority expressed CD8. FOXP3(+)CD4(+) cells were concentrated in the tubules (p < 0.001), suggesting a selective attraction or generation at that site. Considering only patients with ACR, a higher density of FOXP3(+) correlated with HLA class II match (p = 0.03), but paradoxically with worse graft survival. We conclude that infiltration of FOXP3(+) cells occurs in ACR to a greater degree than in humoral rejection, however, within the ACR group, no beneficial effect on outcome was evident. Tregs concentrate in tubules, probably contributing to FOXP3 mRNA in urine; the significance and pathogenesis of 'Treg tubulitis' remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286616     DOI: 10.1111/j.1600-6143.2006.01704.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  48 in total

Review 1.  Why some organ allografts are tolerated better than others: new insights for an old question.

Authors:  Travis D Hull; Gilles Benichou; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

2.  Transient lymphopenia breaks costimulatory blockade-based peripheral tolerance and initiates cardiac allograft rejection.

Authors:  S Iida; T Suzuki; K Tanabe; A Valujskikh; R L Fairchild; R Abe
Journal:  Am J Transplant       Date:  2013-07-08       Impact factor: 8.086

Review 3.  FOXP3-Positive Regulatory T Cells and Kidney Allograft Tolerance.

Authors:  Alessandro Alessandrini; Laurence A Turka
Journal:  Am J Kidney Dis       Date:  2016-12-31       Impact factor: 8.860

4.  Regulation and privilege in transplantation tolerance.

Authors:  Herman Waldmann; Elizabeth Adams; Paul Fairchild; Stephen Cobbold
Journal:  J Clin Immunol       Date:  2008-09-06       Impact factor: 8.317

5.  Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts.

Authors:  Oriol Bestard; Josep M Cruzado; Inés Rama; Joan Torras; Montse Gomà; Daniel Serón; Francesc Moreso; Salvador Gil-Vernet; Josep M Grinyó
Journal:  J Am Soc Nephrol       Date:  2008-05-21       Impact factor: 10.121

Review 6.  Histone deacetylase inhibitors and transplantation.

Authors:  Ran Tao; Edwin F de Zoeten; Engin Ozkaynak; Liqing Wang; Bin Li; Mark I Greene; Andrew D Wells; Wayne W Hancock
Journal:  Curr Opin Immunol       Date:  2007-08-24       Impact factor: 7.486

Review 7.  Kidney transplantation in the elderly.

Authors:  Edmund Huang; Dorry L Segev; Hamid Rabb
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

8.  Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation.

Authors:  Z Wang; B-Y Shi; Y-Y Qian; M Cai; Q Wang
Journal:  Clin Exp Immunol       Date:  2009-01-07       Impact factor: 4.330

Review 9.  Kidney Fibrosis: Origins and Interventions.

Authors:  Thomas Vanhove; Roel Goldschmeding; Dirk Kuypers
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

10.  The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation.

Authors:  J A Bluestone; W Liu; J M Yabu; Z G Laszik; A Putnam; M Belingheri; D M Gross; R M Townsend; F Vincenti
Journal:  Am J Transplant       Date:  2008-10       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.